Elevated plasma phenylalanine predicts mortality in critical patients with heart failure.
Wei-Siang ChenChao-Hung WangChi-Wen ChengMing-Hui LiuChien-Ming ChuHuang-Ping WuPao-Chin HuangYi-Tsen LinTa KoWen-Hsin ChenHuei-Jen WangShu-Chiu LeeChung-Yu LiangPublished in: ESC heart failure (2020)
Elevated phenylalanine levels predicted mortality in critical patients, phenotypically predominantly presenting with HF, independently of traditional prognostic factors and cytokines associated with inflammation and immunity.